197 related articles for article (PubMed ID: 33539574)
21. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120.
Jankovic D; Caspar P; Zweig M; Garcia-Moll M; Showalter SD; Vogel FR; Sher A
J Immunol; 1997 Sep; 159(5):2409-17. PubMed ID: 9278332
[TBL] [Abstract][Full Text] [Related]
22. Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants.
Joshi SS; Arankalle VA
Viral Immunol; 2016; 29(6):350-60. PubMed ID: 27285290
[TBL] [Abstract][Full Text] [Related]
23. RLJ-NE-299A: a new plant based vaccine adjuvant.
Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
[TBL] [Abstract][Full Text] [Related]
24. A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine.
Jamali A; Mahdavi M; Hassan ZM; Sabahi F; Farsani MJ; Bamdad T; Soleimanjahi H; Motazakker M; Shahabi S
Int Immunol; 2009 Mar; 21(3):217-25. PubMed ID: 19174474
[TBL] [Abstract][Full Text] [Related]
25. Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
O'Connell RJ; Excler JL; Polonis VR; Ratto-Kim S; Cox J; Jagodzinski LL; Liu M; Wieczorek L; McNeil JG; El-Habib R; Michael NL; Gilliam BL; Paris R; VanCott TC; Tomaras GD; Birx DL; Robb ML; Kim JH
J Infect Dis; 2016 Jun; 213(12):1946-54. PubMed ID: 26908741
[TBL] [Abstract][Full Text] [Related]
26. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
[TBL] [Abstract][Full Text] [Related]
27. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
[TBL] [Abstract][Full Text] [Related]
28. Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb/C mice.
Mortazavi SS; Haghighat S; Mahdavi M
Microb Pathog; 2020 Mar; 140():103945. PubMed ID: 31874228
[TBL] [Abstract][Full Text] [Related]
29. The effects of CpG-ODNs and Chitosan adjuvants on the elicitation of immune responses induced by the HIV-1-Tat-based candidate vaccines in mice.
Alipour S; Mahdavi A; Abdoli A
Pathog Dis; 2017 Mar; 75(2):. PubMed ID: 28175274
[TBL] [Abstract][Full Text] [Related]
30. Vitamins as influenza vaccine adjuvant components.
Quintilio W; de Freitas FA; Rodriguez D; Kubrusly FS; Yourtov D; Miyaki C; de Cerqueira Leite LC; Raw I
Arch Virol; 2016 Oct; 161(10):2787-95. PubMed ID: 27449155
[TBL] [Abstract][Full Text] [Related]
31. Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.
Beck Z; Matyas GR; Jalah R; Rao M; Polonis VR; Alving CR
Vaccine; 2015 Oct; 33(42):5578-5587. PubMed ID: 26372857
[TBL] [Abstract][Full Text] [Related]
32. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.
Brewer JM; Conacher M; Satoskar A; Bluethmann H; Alexander J
Eur J Immunol; 1996 Sep; 26(9):2062-6. PubMed ID: 8814247
[TBL] [Abstract][Full Text] [Related]
33. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
Krishnan L; Dicaire CJ; Patel GB; Sprott GD
Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
35. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
[TBL] [Abstract][Full Text] [Related]
36. Administration of naloxone in combination with recombinant Plasmodium vivax AMA-1 in BALB/c mice induces mixed Th1/Th2 immune responses.
Someabozorg MA; Mirkazemi S; Mehrizi AA; Shokri F; Djadid ND; Zakeri S
Parasite Immunol; 2015 Oct; 37(10):521-532. PubMed ID: 26234932
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant modulation of the immune response of mice against the LcrE protein of Chlamydophila pneumoniae.
Faludi I; Burian K; Csanadi A; Miczak A; Lu X; Kakkar VV; Gonczol E; Endresz V
Int J Med Microbiol; 2009 Nov; 299(7):520-8. PubMed ID: 19451031
[TBL] [Abstract][Full Text] [Related]
38. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
[TBL] [Abstract][Full Text] [Related]
39. Nanocurcumin as an adjuvant in killed Toxoplasma gondii vaccine formulation: An experience in BALB/c mice.
Mahdi Ghahari SM; Ajami A; Sadeghizadeh M; Esmaeili Rastaghi AR; Mahdavi M
Exp Parasitol; 2022 Dec; 243():108404. PubMed ID: 36265591
[TBL] [Abstract][Full Text] [Related]
40. A novel adjuvant, the mixture of alum and naltrexone, augments vaccine-induced immunity against Plasmodium berghei.
Shahabi S; Azizi H; Mazloomi E; Tappeh KH; Seyedi S; Mohammadzadeh H
Immunol Invest; 2014; 43(7):653-66. PubMed ID: 25020077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
